REVIEW
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
Alzheimer’s disease; artificial intelligence; clinical trials; eligibility assessment; randomization
Online: 8 October 2021 (11:31:14 CEST)